Preeclampsia is still called the "disease of theories" because its direct cause is still debated. Patients, providers, researchers, and funders remain critical to moving preeclampsia research forward. Our research goal is four-fold:
We are working to help research move forward to better understand how to diagnose, treat, and eventually prevent the poor outcomes preeclampsia can have on patients and their families. Learn more about the actions we've taken and the results we've discovered.
LEARN MORE
You are not alone. A hypertensive disorder of pregnancy like preeclampsia or HELLP syndrome can be a life-changing experience. You may be looking for a way to make that same experience better for other patients like you.
By sharing the details of your experience and reporting back regularly, you provide valuable insights for medical researchers. This kind of condition-specific database which directly aids research is called a Registry. Your privacy, the information you share, and the kinds of research studies you wish to participate in are controlled by you.
LEARN MORE
Apply for research grant funding, use our study recruitment services, or engage patient partners in your research.
LEARN MORE
Many women who suffer a preeclampsia or HELLP syndrome experience are left with many unanswered questions about why it may have happened to them or how to prevent it. Our "Ask An Expert" series presents questions posed by Preeclampsia Registry participants and answered by preeclampsia research experts, citing the most recent peer-reviewed evidence.
LEARN MORE
The most important preeclampsia research studies, explained for you. The Research Roundup team consists of diverse researchers who scour the peer-reviewed research journals to highlight the most important, recently published studies in the field of preeclampsia. The results of these studies, which cover everything from basic science to clinical care practices, are summarized in plain language with an explanation of what the results could mean for you, and distributed in specialized Expectations Research editions.
LEARN MORE
Finding a cure for preeclampsia goes beyond funding individual research studies - it involves advocating at a systematic level for the prioritization of maternal and fetal health as a national (and international) issue that can and should be addressed. Quality improvement research shows that there is room for advancements at all levels of the maternal health experience: education, diagnosis, management, treatment, and prevention. For that reason, the Preeclampsia Foundation and our partners advocate to improve the diagnosis, treatment and prevention of hypertensive disorders of pregnancy.
LEARN MORE
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
1732072344.png)
While the Preeclampsia Foundation has been championing patient advocacy and representation for all families affected by hypertension in pregnancy throughout our 25 year history, we recognized the uniq...
Genetic predictors of blood pressure traits are associated with preeclampsia Although underlying causes of preeclampsia are not fully understood, there is evidence suggesting a strong genetic compone...
Hypertensive disorders of pregnancy (HDP) are a leading cause of maternal mortality and can put both mother and baby at risk for problems during pregnancy. Women who had HDPs have postpartum risk...
Elevated Blood Pressure in Pregnancy and Long-Term Cardiometabolic Health Outcomes This study looked at how elevated blood pressure during the third trimester of pregnancy affects cardiometabolic hea...
Planned early-term delivery in individuals with mild chronic hypertension was not associated with a reduction in adverse maternal outcomes but was associated with an increase in some neonatal complica...
